Edmonton-based Entos Pharmaceuticals, led by University of Alberta researcher Dr. John Lewis, began Phase 1 of its clinical trial Thursday. Source


And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.